"Headline (2025-12-31): Revenue $0.95M, Net Income -$92.6M, EPS -3.56. YoY growth: not computable from the provided dataset because prior-year (2024) quarters are not included. QoQ (vs 2025-09-30): Revenue rose from $0.45M to $0.95M (+109%), but profitability deteriorated sharply—net income fell from -$35.9M to -$92.6M (net loss widened). Over the 4-quarter window, results were highly volatile: net income was positive in 2025-06-30 (+$15.9M) but negative in 2025-03-31 (-$17.7M) and again in the last two quarters (down -$35.9M to -$92.6M). Net margins therefore contracted materially overall, with the most recent quarter showing extremely weak margin given the large loss relative to revenue. Cash flow quality remains weak: operating cash flow and free cash flow were consistently negative each quarter (FCF roughly -$16.9M to -$24.2M), with no dividends paid and no evidence of sustained cash generation. Balance sheet resilience is a concern: total equity moved from slightly negative near mid-year to a much more negative position by 2025-12-31 (-$126.2M), indicating increasing leverage/insolvency risk despite net debt being negative (net cash). Total shareholder returns appear poor: the stock is down -53.92% over the last year, with no dividend support and no provided buyback activity. Although the consensus price target is 16 (above the current price of 5.99), the near-term fundamentals do not yet support stability."

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.